טוען...
Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis
BACKGROUND: Lacosamide (LCM) is the antiepileptic drug approved by the U.S. Food and Drug Administration in 2008 that facilitates slow activation of the voltage-gated sodium channels. Neutropenia and cardiac events including sinus node dysfunction (SND) and atrioventricular block have been previousl...
שמור ב:
| הוצא לאור ב: | BMC Neurol |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8185934/ https://ncbi.nlm.nih.gov/pubmed/34102997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-021-02253-1 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|